Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Lymphoma

  Free Subscription


20.07.2026

1 Am J Surg Pathol
2 Blood
1 BMC Cancer
1 Bone Marrow Transplant
1 Br J Cancer
4 Br J Haematol
3 Cancer
3 Haematologica
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
2 Leuk Lymphoma
4 Leukemia
1 Mol Ther Oncol
1 PLoS Med
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. WU SJ, Hergott CB, Griffin GK, Lane AA, et al
    The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.
    Am J Surg Pathol. 2026;50:872-882.
    PubMed         Abstract available


    Blood

  2. WANG M, Hoffmann MS, Wrobel T, Trneny M, et al
    First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients >/=65 years or with TP53 mutations.
    Blood. 2026 Jul 1:blood.2025032833. doi: 10.1182/blood.2025032833.
    PubMed         Abstract available


  3. Chihara D, Dores GM, Flowers CR, Morton LM. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma. Blood. 2021;138(9):785-789.
    Blood. 2026;148:389.
    PubMed        


    BMC Cancer

  4. TAN MW, Ling V, Tan JY, Chan WL, et al
    Autologous stem cell transplantation for secondary central nervous system lymphoma: a multicentre retrospective analysis.
    BMC Cancer. 2026 Jul 14. doi: 10.1186/s12885-026-16531.
    PubMed         Abstract available


    Bone Marrow Transplant

  5. SAHA A, Whiting J, Mohty R, Flores K, et al
    A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.
    Bone Marrow Transplant. 2026 Jul 17. doi: 10.1038/s41409-026-02936.
    PubMed         Abstract available


    Br J Cancer

  6. HOUMERA N, Genestier L, Huet S
    Next-generation models for lymphoid malignancies: the rise of 3D culture systems in translational hematology.
    Br J Cancer. 2026;135:336-348.
    PubMed         Abstract available


    Br J Haematol

  7. ABEYAKOON C, Wellard C, Murad V, Chung E, et al
    End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.
    Br J Haematol. 2026 Jul 17. doi: 10.1111/bjh.70689.
    PubMed         Abstract available

  8. WILLIAMS S, Lim YJ, Cooper R, Gamble C, et al
    Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.
    Br J Haematol. 2026 Jul 16. doi: 10.1111/bjh.70656.
    PubMed        

  9. PORGES T, Levi T, Dann EJ, Aumann S, et al
    Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.
    Br J Haematol. 2026 Jul 14. doi: 10.1111/bjh.70682.
    PubMed         Abstract available

  10. WANG M, Jurczak W, Trneny M, Belada D, et al
    Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.
    Br J Haematol. 2026 Jul 12. doi: 10.1111/bjh.70620.
    PubMed        


    Cancer

  11. THARMASEELAN H, Jablonski J, Buhnen I, Fuchs M, et al
    Prognostic impact of presentation phenotypes in early-stage favorable Hodgkin lymphoma.
    Cancer. 2026;132:e70532.
    PubMed         Abstract available

  12. SUZUKI K, Miyazaki K, Yamaguchi M
    Reply to "Pulmonary mucosa-associated lymphoid tissue lymphoma: Is gastric involvement underdiagnosed?".
    Cancer. 2026;132:e70535.
    PubMed        

  13. COUDERC LJ, Catherinot E
    Pulmonary mucosa-associated lymphoid tissue lymphoma: Is gastric involvement underdiagnosed?
    Cancer. 2026;132:e70534.
    PubMed        


    Haematologica

  14. DLOUHY I, Maia T, Viegas D, Abreu N, et al
    Notable clinical activity of immune checkpoint inhibitors with or without brentuximab vedotin in relapsed or refractory gray zone lymphoma.
    Haematologica. 2026 Jul 16. doi: 10.3324/haematol.2026.301128.
    PubMed         Abstract available

  15. YLSTRA B, Groenen PJTA, Los-de Vries T, Janssen J, et al
    Enteropathy-associated T-cell lymphoma: molecular clonal evolution and its clinical consequences.
    Haematologica. 2026 Jul 16. doi: 10.3324/haematol.2026.300770.
    PubMed         Abstract available

  16. EICHENAUER DA, Buhnen I, Basaran A, Fuchs M, et al
    Comparison and combination of prognostic scores for nodular lymphocytepredominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.
    Haematologica. 2026 Jul 16. doi: 10.3324/haematol.2026.300633.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  17. CEDERQUIST G, Yahalom J, Imber BS
    A Little Less Gray: Reduced Dose Whole Brain Radiation Therapy Consolidation in Primary Central Nervous System Lymphoma Proves to Be a Winner in a Key Randomized Study.
    Int J Radiat Oncol Biol Phys. 2026;125:1421-1423.
    PubMed        


    J Clin Oncol

  18. EYRE TA, Song Y, Hermine O, Shuang Y, et al
    Erratum: Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.
    J Clin Oncol. 2026 Jul 14:JCO2601699. doi: 10.1200/JCO-26-01699.
    PubMed        

  19. LADETTO M, Gutmair K, Tavarozzi R, Pawlikowski A, et al
    Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.
    J Clin Oncol. 2026 Jul 14:JCO2600705. doi: 10.1200/JCO-26-00705.
    PubMed         Abstract available


    Leuk Lymphoma

  20. MACMANUS M, Dowling M
    The role of radiotherapy in bridging to CAR T-cell therapy for high-grade B-cell lymphoma.
    Leuk Lymphoma. 2026 Jul 16:1-3. doi: 10.1080/10428194.2026.2694679.
    PubMed        

  21. BELGHOUL M, Kuhnl A, Chevassut T, Sanderson R, et al
    The impact of radiotherapy on the therapeutic response of patients treated with CAR T-cell therapy for high-grade lymphoma: a systematic review.
    Leuk Lymphoma. 2026 Jul 16:1-9. doi: 10.1080/10428194.2026.2685253.
    PubMed         Abstract available


    Leukemia

  22. LIU H, Cheng Y, Liu S, Zhang X, et al
    Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial.
    Leukemia. 2026 Jul 16. doi: 10.1038/s41375-026-03059.
    PubMed         Abstract available

  23. PHYU T, Leong SM, Chen S, Gu W, et al
    DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.
    Leukemia. 2026 Jul 15. doi: 10.1038/s41375-026-03043.
    PubMed         Abstract available

  24. FUSANI S, Davini A, Rossi A, Mazzara S, et al
    Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma.
    Leukemia. 2026 Jul 13. doi: 10.1038/s41375-026-03042.
    PubMed        

  25. MORI Y, Suto K, Takei N, Yokoyama K, et al
    PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.
    Leukemia. 2026 Jul 13. doi: 10.1038/s41375-026-03055.
    PubMed         Abstract available


    Mol Ther Oncol

  26. SUPPIPAT K, Tawinwung S, Sathitakorn O, Chanswangphuwana C, et al
    Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings.
    Mol Ther Oncol. 2026;34:201278.
    PubMed         Abstract available


    PLoS Med

  27. THRUN MC, Hoffmann J, Krause SW, Krawitz P, et al
    Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study.
    PLoS Med. 2026;23:e1004889.
    PubMed         Abstract available


    PLoS One

  28. RJOOP A, Al-Samama'h R, Al-Ullemat TS, Alshamali R, et al
    Clinical characteristics and outcomes of Hodgkin Lymphoma: A single institution retrospective cohort study.
    PLoS One. 2026;21:e0353363.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum